INTERPHEX 2026: Avantor, BioLife Solutions, AES Highlights

Key Takeaways

• Avantor unified its Masterflex portfolio, streamlining fluid management solutions for bioprocessing.
• BioLife Solutions' CellSeal CryoCase won the INTERPHEX 2026 Biotech Innovation Award.
• AES Cleanroom Technology celebrates 40 years of enabling ATMP approvals for companies like Genentech and Novartis.

INTERPHEX 2026, held in New York City from April 21-23, showcased the latest innovations in pharmaceutical and biotechnology manufacturing. Key announcements included Avantor's unified fluid management portfolio, BioLife Solutions' award-winning cryogenic containment system, and AES Cleanroom Technology's 40th-anniversary celebration.

Event Context and Significance

INTERPHEX is a premier event for the pharmaceutical, biotechnology, and device industries, bringing together suppliers, manufacturers, and industry professionals. The announcements made at INTERPHEX 2026 highlight ongoing advancements in bioprocessing, cell and gene therapy, and cleanroom technology, reflecting the industry's focus on efficiency, safety, and scalability.

Avantor's Fluid Management Solutions

Avantor (NYSE: AVTR) announced the unification of its Masterflex® portfolio, which now includes a comprehensive range of standard, configurable, and engineered-to-order peristaltic pumps, single-use assemblies, and systems designed for fluid management across the entire spectrum from R&D to bioprocess manufacturing. This consolidation aims to streamline processes and provide integrated solutions for its customers.

At Booth #3643, Avantor showcased these integrated fluid management systems, including tangential flow filtration (TFF), storage, and pump solutions. Zeiny Aubdoollah, Scientist, R&D Applications, delivered a technical presentation on fluid handling technologies supporting scalability, featuring a study on Avantor Magnetic Mixers.

BioLife Solutions' Biotech Innovation Award

BioLife Solutions (NASDAQ: BLFS) received the INTERPHEX 2026 Biotech Innovation Award for its CellSeal® CryoCase. This rigid cryogenic containment system is designed for frozen biologics and was launched in 2025. The CellSeal® CryoCase addresses common issues related to cryobag failures during freezing, liquid nitrogen storage, distribution, and inspection, and is compatible with closed-system cell and gene therapy (CGT) workflows.

AES Cleanroom Technology's 40th Anniversary

AES Cleanroom Technology marked its 40th anniversary at INTERPHEX 2026, celebrating a history of building over 4,000 facilities and receiving 16 ISPE Facility of the Year Awards. The company highlighted its support for major clients, including Genentech, CRISPR Therapeutics, Bristol-Myers Squibb, and Novartis. AES Cleanroom Technology's cleanrooms have enabled the approvals of several key ATMPs, including Provenge (2010), Luxturna (2017), Kymriah (2018), Amtagvi (2024), and Adaptimmune T-cell therapy (2024).

Danaher (Cytiva) Showcase

Danaher's (Cytiva) showcase at INTERPHEX featured the Fibro dT, a next-generation mRNA purification platform designed to reduce processing time, increase yield, and lower material use. Cytiva also presented its next-generation automated perfusion system (APS).

Market & Investor Implications

The innovations presented at INTERPHEX 2026 reflect the ongoing growth and evolution of the biopharmaceutical industry. Avantor's unified Masterflex portfolio addresses the need for streamlined fluid management solutions, while BioLife Solutions' CellSeal CryoCase tackles critical challenges in cell and gene therapy. AES Cleanroom Technology's long-standing expertise in cleanroom design and construction continues to support the development and manufacturing of advanced therapies.

What to Watch Next

The industry will be closely watching the adoption and impact of these new technologies. Further developments in mRNA purification, automated perfusion, and cryogenic storage will likely be key areas of focus in the coming years.

Frequently Asked Questions

• What is INTERPHEX?

  INTERPHEX is a trade show for the pharmaceutical, biotechnology, and device industries.

• What is Avantor's Masterflex portfolio?

  Masterflex is Avantor's brand of peristaltic pumps, single-use assemblies, and fluid management systems.

• What is CellSeal CryoCase?

  CellSeal CryoCase is BioLife Solutions' rigid cryogenic containment system for frozen biologics.

• What is AES Cleanroom Technology known for?

  AES Cleanroom Technology designs and builds cleanrooms for pharmaceutical and biotech manufacturing.

• What were some key ATMP approvals enabled by AES Cleanroom Technology?

  Provenge, Luxturna, Kymriah, Amtagvi and Adaptimmune T-cell therapy.

References

• Avantor Unifies Masterflex Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing
• BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal CryoCase
• BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal
• AES Cleanroom Technology: 40 Years Modular INTERPHEX 2026
• BioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal